I

Iterative Health

AI-powered polyp detection for colorectal cancer

Technical Services Engineer - Site Infrastructure & Enablement

Full-TimeUpdated on 10/23/2026
$85k - $115k
Mid
Bachelor's
Cambridge, MA, USA+1 moreMore locations: New York, NY, USA
HybridHybrid: in-office collaboration two days per week in either the NYC or Boston office; periodic travel to managed clinical sites.
IT OperationsIT Service Desk & End User Support

About the job

Requirements
  • A bachelor's degree in Information Technology, Computer Science, Healthcare Administration, Clinical Research, Life Sciences, or Business Operations, or equivalent professional experience.
  • At least 3 years of relevant experience supporting clinical research sites, healthcare operations, technical services, field support, IT, or comparable multi-site environments.
  • Ability to independently own Tier 1 support requests from intake through resolution, including triage, troubleshooting, escalation, stakeholder communication, and follow-up.
  • Experience supporting clinical or healthcare technology, including end-user hardware, software, peripherals, connectivity, applications, electronic health records, and other site systems.
  • Experience supporting site equipment and technology throughout its lifecycle, including procurement, inventory, shipping, deployment, installation, troubleshooting, replacement, and asset management.
  • Experience coordinating with external vendors and service providers, including equipment installation, service delivery, vendor assessments, and MSA or similar contracting workflows.
  • Working knowledge of clinical research site operations and workflows, including site enablement, pre-startup activities, and study readiness.
  • Experience working with electronic health records, clinical systems, or healthcare data, including patient-population queries to support site selection or pre-startup activities.
  • Ability to provide backup pre-screening support using established study criteria, processes, systems, and escalation pathways.
  • Strong troubleshooting, analytical, organizational, and root-cause-analysis skills, with demonstrated ownership and ability to operate independently.
  • Excellent written and verbal communication skills with a customer- and site-service-oriented mindset.
  • Ability to prioritize multiple requests and projects in a fast-paced, rapidly changing environment while collaborating across functional teams.
  • Willingness to travel to managed clinical sites as needed.
Responsibilities
  • Own Tier 1 support for all managed sites, serving as a primary point of contact for site questions, requests, and issues; triage requests, resolve issues within scope, coordinate escalation when needed, and follow requests through resolution.
  • Own medical equipment support and requests for site build-outs, including identifying equipment needs, coordinating requests, tracking status, and working with internal stakeholders and external vendors to support new and existing sites.
  • Identify ancillary-services vendors for managed sites by researching potential vendors, assessing service capabilities and site requirements, coordinating vendor engagement, and supporting establishment of required services.
  • Provide backup pre-screening support until additional dedicated pre-screening resources are hired, using established study criteria, workflows, systems, and escalation pathways.
  • Triage and support resolution of technical requests for all managed sites, coordinating across internal teams, vendors, and site personnel to troubleshoot and resolve hardware, software, system, connectivity, equipment, and other technology-related issues.
  • Support procurement and logistics for all managed sites, including purchasing coordination, shipping, receiving, inventory, equipment movement, replacement, and related logistics required to support site operations.
  • Support equipment installation and setup for new site build-outs, including medical and technical equipment, and coordinate with site personnel, vendors, IT, and other stakeholders to ensure equipment is installed, configured, documented, and operational.
  • Document Site Infrastructure & Enablement processes, including site configurations, equipment and vendor information, support procedures, and knowledge resources, to improve consistency, scalability, and operational efficiency.
  • Partner with Site Operations, Clinical Operations, IT, Quality, Regulatory, and other stakeholders to identify and implement improvements to site-support processes.
  • Travel periodically to managed clinical sites to support site build-outs, equipment installations, troubleshooting, and other onsite activities.
  • Perform related duties as requested.
Desired Qualifications
  • Experience completing or supporting Feasibility Questionnaires, Vendor Assessments, and InfoSec Assessments for clinical research sites and studies.
  • Experience providing Tier 1 support for Compliance and Quality Management Systems, including familiarity with Computer System Validation and 21 CFR Part 11 validation requirements.
  • Experience administering or supporting clinical research systems and applications, including RealTime, CRIO, CTMS, Salesforce, and EHR integrations.
  • Experience deploying and managing CTMS templates, including study, financial, and eSource templates, and supporting Salesforce data integrity, dashboards, and verification/validation.
  • Experience supporting EHR integration implementation, video-recording workflows, and other specialized clinical technology across sites and vendors.
  • Experience working directly with clinical research sites, investigators, research coordinators, sponsors, contract research organizations, and/or clinical-service vendors.
  • Familiarity with Good Clinical Practice, clinical research regulatory requirements, data privacy, and healthcare technology environments.
  • Experience supporting technology and operations across a multi-site healthcare or clinical research organization.

About the company

Iterative Health develops and deploys AI-powered tools for gastrointestinal (GI) care. Its main product is SKOUT®, an FDA-cleared device that helps doctors find adenomas (polyps) during GI procedures, supporting clinical judgment rather than replacing it. The company also offers AI-enabled documentation and data standardization technologies to improve the quality of patient care and to streamline clinical trials, enabling consistent reporting across institutions. By combining AI image analysis, data-driven insights, and streamlined research workflows, Iterative Health aims to improve colorectal cancer prevention and diagnosis and to extend high-quality GI care to underserved populations around the world.

Company Size

201-500

Company Stage

Series C

Total Funding

$262.2M

Headquarters

Boston, Massachusetts

Founded

2017

Get referred to Iterative Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 30, 2026 Series C raised $77 million from GV and Intrepid Growth Partners.
  • July 2026 partnerships with GANJ and US Heart & Vascular widened patient access.
  • September 2026 leadership hires, including Dr. Nadege Gunn and Dr. Samin Sharma, sharpen credibility.

What critics are saying

  • Cardiology and obesity expansion now competes against entrenched site networks and academic centers.
  • SKOUT’s 510(k) clearance stays limited to colonoscopy, so product moat remains narrow.
  • If sponsor demand softens, Iterative’s labor-heavy site model strains margins and growth by 2027.

What makes Iterative Health unique

  • Iterative Health combines AI software, centralized operations, and embedded community research sites.
  • SKOUT has FDA clearance for real-time polyp detection during white-light colonoscopy only.
  • The network spans 110-plus sites across GI, hepatology, obesity, and cardiology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Vision/Dental/ Medical Insurance
  • Life/Disability Insurance
  • Parental Leave
  • Stock Options
  • Flexible Work Hours
  • Unlimited Paid Time Off

Growth & Insights and Company News

6 month growth

1%

1 year growth

0%

2 year growth

-4%
Associated Press
Aug 11th, 2026
Iterative Health appoints Mount Sinai's Dr Samin K. Sharma as honorary chair of interventional cardiology

Iterative Health has appointed Dr Samin K. Sharma as scientific advisor and honorary chair of interventional cardiology. Dr Sharma is director of the Cardiovascular Clinical Institute at Mount Sinai Hospital and director of interventional cardiology at Mount Sinai Health System. Dr Sharma has over 30 years of experience and has authored more than 350 peer-reviewed articles. He pioneered the use of the Rotablator technique for complex coronary blockages. The appointment follows Iterative Health's recent US site network expansion, including acquiring cardiology research sites from NextStage Clinical Research and partnering with US Heart & Vascular. The company's network spans more than 100 sites across three continents in GI, hepatology, obesity, and cardiology research.

Business Wire
Aug 11th, 2026
Iterative Health appoints Dr. Samin K. Sharma at Mount Sinai Hospital as honorary chair of Interventional Cardiology.

Iterative Health appoints Dr. Samin K. Sharma at Mount Sinai Hospital as honorary chair of Interventional Cardiology. CAMBRIDGE, Mass.-(BUSINESS WIRE)-Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced the appointment of Samin K. Sharma, MD, FACC, MSCAI, Director of the Cardiovascular Clinical Institute at The Mount Sinai Hospital, as a scientific advisor and honorary chair of Interventional Cardiology. In this role, Dr. Sharma brings best-in-class clinical and scientific leadership from one of the foremost academic medical centers to advance the company's cardiology strategy. "Dr. Sharma is a world-renowned physician recognized for his clinical judgment, commitment to patient-centered care, and contributions to the field," said Jonathan Ng, founder and CEO of Iterative Health. "His experience will help strengthen our therapeutic expertise, protocol and trial design, and scientific publications, ultimately helping our sites move studies forward with the excellence and rigor sponsors expect." Dr. Sharma is director of the S.P. and Seema Lohia Cardiovascular Clinical Institute and director of interventional cardiology at Mount Sinai Health System, where he also serves as president of the Mount Sinai Heart Network. With more than 30 years of experience, he is one of the most awarded cardiologists for his contributions to medical science. He is also credited with pioneering the use of the Rotablator technique for complex, calcified coronary blockages, has authored more than 350 peer-reviewed articles, and sits on the editorial boards of several cardiology journals. Dr. Sharma is passionate about medical education, mentoring fellows and experienced cardiologists alike through innovative teaching methods, including symposiums and live-broadcast cases that reach thousands. "There's a real gap between what a trial protocol asks for and what's actually workable at the bedside, and it can cost a study valuable time," said Dr. Sharma. "Iterative Health has built a research network around closing that gap, and it's an honor to help the company strengthen its impact in advancing cardiology research." The appointment follows Iterative Health's recent US site network expansion, including the acquisition of established cardiology research sites from NextStage Clinical Research and a strategic partnership with US Heart & Vascular. The company's network spans more than 100 high-performing sites across three continents in GI, hepatology, obesity, and cardiology research. About Iterative Health Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need. The company has headquarters in Cambridge, Massachusetts, and New York, New York. For more information, visit www.iterative.health and follow us on LinkedIn for the latest company updates. Contacts. Media Contact Iterative Health: Andrea Sampson President/CEO, Sampson Public Relations Group [email protected] More News From Iterative Health CAMBRIDGE, Mass.-( BUSINESS WIRE )-Iterative Health and Gastroenterology Associates of New Jersey partnered to expand access to GI clinical research in New Jersey... CAMBRIDGE, Mass.-( BUSINESS WIRE )-Iterative Health announced the acquisition of three cardiology sites from NextStage Clinical Research... CAMBRIDGE, Mass.-( BUSINESS WIRE )-Iterative Health announced the presentation of updated scientific research at Digestive Disease Week (DDW) 2026...

Associated Press
Jul 8th, 2026
Iterative Health partners with GANJ to expand GI clinical research across New Jersey

Iterative Health has partnered with Gastroenterology Associates of New Jersey (GANJ) to expand clinical research access across New Jersey. The collaboration establishes two research sites in Toms River and Clifton, joining Iterative Health's network of over 110 sites globally. GANJ operates 28 locations across New Jersey with more than 60 healthcare professionals. The partnership integrates clinical research into community GI care, leveraging New Jersey's population of over 9.5 million residents and its ethnic diversity. Iterative Health will serve as GANJ's research partner, combining the practice's clinical expertise with its AI-powered technology and operational model. The collaboration focuses particularly on inflammatory bowel disease, with GANJ recently establishing a Comprehensive IBD Care Centre. Additional research sites are under discussion across GANJ's broader provider network. Iterative Health operates the largest community-embedded research site network in the US for GI, hepatology, obesity, and cardiology clinical development.

Planet First Partners
Jun 30th, 2026
Iterative Health raises $77M Series C to accelerate clinical trials with AI-powered research network

Planet First Partners has invested in Iterative Health, a healthcare technology company focused on accelerating clinical research. The investment follows Iterative Health's recent $77 million Series C funding round led by Intrepid Growth Partners and Google Ventures, with participation from EDBI, a family office, Insight Partners, and Obvious Ventures. Iterative Health operates a clinical research network spanning over 100 sites across North America, Europe, India, and Australia. The company uses AI and centralised operations to improve trial efficiency, achieving twice faster site activation and three times higher patient enrolment compared to industry standards. The Series C funds will support expansion into cardiology and obesity research, building on the company's existing focus on gastroenterology and hepatology. Iterative Health partners with over 40 pharmaceutical, biotech, and CRO organisations.

Business Wire
May 14th, 2026
Iterative Health acquires 3 cardiology sites from NextStage Clinical Research in Texas

Iterative Health, a healthcare technology and services company, has acquired three cardiology research sites in Texas from NextStage Clinical Research. The sites, located in Beaumont, Port Arthur and Waco, bring experienced research teams and established cardiovascular trial operations. The acquisition expands Iterative Health's cardiology footprint as part of its strategy to embed clinical research within community care settings. The company operates over 100 sites across three continents, supported by a 250-person team and proprietary AI tools for patient recruitment and trial design. Cardiovascular disease affects nearly half of US adults, yet clinical trial access remains uneven. The addition strengthens Iterative Health's capabilities across therapeutic areas including gastroenterology, hepatology and obesity, whilst providing patients access to innovative cardiovascular therapies and devices.